Endogenous biomarkers play a pivotal role in comprehending drug-body interactions, shaping drug development, and propelling precision medicine forward. With our latest software release, the Simcyp™ Simulator introduces innovative features tailored to endogenous biomarkers. In a comprehensive overview led by our expert presenter, Dr. Matthew Harwood, Principal Scientist in Translational DMPK, shares insights into: Dr. Harwood … Continued
会場：Certara UK OfficesLevel 2-Acero1 Concourse WaySheffieldUnited Kingdom Online registration is available until: 6/29/2024 The workshop is neither trying to provide a 101 course on LCMS proteomics nor attempts to focus on what is new in LC-MS proteomics techniques. Attendees need to have some background but not necessarily leading experts in the field.
In the ever-evolving pharmaceutical landscape, advancing drug development requires innovative tools that seamlessly integrate science and regulatory standards. The release of Simcyp™ PBPK Simulator Version 23 provides an even more comprehensive platform for all stages of drug development. Physiologically Based Pharmacokinetic (PBPK) modeling is a cornerstone in drug development, providing predictive insights into drug behavior … Continued
On-site Workshop Overview Regulatory approval procedures are becoming increasingly stringent and time-consuming. 適切な規制対応戦略を未構築のままでは、多くの時間と費用の浪費するだけでなく、最悪の場合には、開発計画の失敗や大幅な遅延に繋がる恐れがあります。It relayed to potential of Generative AI how it can help overcome those regulatory challenges. The emergence … Continued
The Pharmacokinetics (PK) of ADC therapeutics typically show a discrepancy between the PK of total antibody and that of conjugated antibody, carrying one or more payload molecules. This discrepancy is often attributed to deconjugation, however recent evidence suggests that the underlying mechanisms may be more complex. In this webinar, we will present how quantitative systems … Continued
